View Document Preview and Link Document Date: 2012-06-27 15:00:54 Open Document File Size: 848,61 KB Share Result on Facebook
City St. Laurent / Cambridge / / Company ACS / AEs / Momenta Pharmaceuticals Inc / / Facility American College of Cardiology/American Heart Association Task Force / / MedicalCondition Infusion site erythema / Patients With Unstable Angina/Non STElevation Myocardial Infarction / acute coronary syndromes / Patients With ST-Elevation Myocardial Infarction / heparin-induced thrombocytopenia / Unstable Angina/Non ST-elevation Myocardial Infarction / thrombocytopenia / / MedicalTreatment intravenous infusion / adjunctive therapy / / Organization the American College / Cardiology/American Heart Association Task Force on Practice / Cardiology/American Heart Association Task Force on Practice Guidelines / / Position King / / Product PROTAMINE SULFATE / Placebo injection / / ProvinceOrState Quebec / / Technology Pharmacokinetics / Pharmacodynamics / / SocialTag 
M118, A NOVEL, RATIONALLY ENGINEERED LOW MOLECULAR WEIGHT HEPARIN, WITH POTENT ANTI-XA AND ANTI-IIA ACTIVITIES IS REVERSIBLE BY PROTAMINE SULFATE, AND MONITORABLE WITH ACT FOLLOWING MULTIPLE IV INJECTIONS I. Fier , M. A